Loading...
Abcam plc
ABCZF•PNK
Healthcare
Biotechnology
$22.25
$0.15(0.68%)

The company's financials show resilient growth, with revenue advancing from $65.00M in Q4 2019 to $65.00M in Q3 2020. Gross profit remained healthy with margins at 69% in Q3 2020 compared to 69% in Q4 2019. Operating income hit $2.48M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $9.95M. Net income rose to $3.13M, while earnings per share reached $0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan